---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-070569"
form_type: "8-K"
ticker: "PSTV"
cik: "0001095981"
company_name: "PLUS THERAPEUTICS, INC."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:28:01.905550+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Plus Therapeutics CMO Dr. Norman LaFrance resigns effective June 12, 2024

## Summary
- Dr. Norman LaFrance resigned as Chief Medical Officer on June 5, 2024.
- Resignation effective June 12, 2024; no reason provided in the filing.
- No successor or interim CMO announced; President & CEO Marc Hedrick signs 8-K.
- Company trades on Nasdaq under ticker PSTV.

## SEC filing metadata
- accession: 0000950170-24-070569
- form_type: 8-K
- ticker: PSTV
- cik: 0001095981
- company_name: PLUS THERAPEUTICS, INC.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1095981/000095017024070569/0000950170-24-070569-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1095981/000095017024070569/pstv-20240605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-070569
- JSON: https://secwatch.observer/filing/0000950170-24-070569.json
- Plain text: https://secwatch.observer/filing/0000950170-24-070569.txt

## Key facts
- Executive change
  Dr. Norman LaFrance resigned as Chief Medical Officer at PLUS THERAPEUTICS, INC..
  - Action: resigned
  - Role: Chief Medical Officer
  source text: On June 5, 2024, Plus Therapeutics, Inc. (the “Company”) received the resignation of Dr. Norman LaFrance, its Chief Medical Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1095981/000095017024070569/0000950170-24-070569-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.